Real-time Quantification of BCR-ABL mRNA Transcripts Using the LightCycler-t(9;22) Quantification Kit
نویسندگان
چکیده
Literature indicates that in 95 % of all subjects with chronic myeloid leukemia (CML) and in 25-30 % of subjects with acute lymphoblastic leukemia (ALL) a reciprocal translocation between the long arms of chromosome 9 and chromosome 22 [t(9;22)] can be found. This translocation or the resulting fusion product can be detected by a number of techniques, including fluorescent in situ hybridization, Southern blotting, western blotting and reverse transcriptase polymerase chain reaction (RT-PCR). Of these techniques, RT-PCR for the chimeric fusion transcript BCRABL has received most attention in relation to the detection of minimal residual disease because of its high sensitivity (1). Attempts to research the remission and relapse events, occurring in the body of persons with CML after treatment with interferon-a or after bone marrow transplantation, requires sensitive techniques that detect smallest amounts of residual leukemic cells. Research concerning a possible correlation between a positive nested RT-PCR signal and the progression of the leukemia is hampered by the nonquantitative nature of conventional nested RT-PCR. Quantitative RT-PCR approaches that allow quantification of the transcript by competitive RT-PCR have been developed (2,3). The technique is based on serial dilutions of competitor contructs added to a constant amount of sample cDNA. Quantification is achieved by comparison of the relative band intensities of target and competitor PCR product on agarose gel. However, this method is very laborious since several concentrations of the competitor have to be used to cover the expected concentration range. In this article we present the LightCycler-t(9;22) Quantification Kit which is a research tool designed for the further study of possible relationships between the level of BCR-ABL fusion transcripts expression, stage of the disease, and response to treatment. The LightCycler System approach for the quantitative detection of the BCR-ABL fusion transcripts is based on real-time detection. The wide dynamic range of real-time PCR enables simultaneous analysis of samples with highly different starting concentrations, so that the initial target concentration can be determined in a single PCR. The concentration of BCR-ABL transcripts is determined relative to the number of transcripts of a control gene, glucose-6-phosphate dehydrogenase (G6PDH). The entire procedure from sample preparation to quantitative result is performed in 4.5 hours.
منابع مشابه
A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase
Dear Editor CML is characterized by the clonal expansion of bone marrow hematopoietic cells and is associated with the Philadelphia chromosome [1]. The accelerated phase of CML, which is also known as the blast crisis phase, occurs in patients as the disease progresses. It has been reported that the appearance of an additional chromosomal abnormality is the major pathogenic factor in 63% of the...
متن کاملAbsolute quantification of murine interleukine-4, interleukine- 10 and interferon-γ gene transcripts using Real Time PCR
The study of cytokines gene expression is quite important in various conditions of health and disease for the evaluation of clinical responses to new vaccination approaches. An absolute quantification is based on a calibration curve and production of standard controls to achieve more reliable results than in relative system. In this study we attempted to construct standard controls to evaluate ...
متن کاملFrequency of BCR-ABL Fusion Transcripts in Iranian Azeri Turkish patients with Chronic Myeloid Leukemia
Background: The Philadelphia chromosome (Ph) characterized by t (9; 22) (q34; q11.2) is a reciprocal translocation giving rise to a chimeric BCR-ABL fusion gene. Incidence of Ph chromosome is over 98% in Patients with Chronic Myeloid Leukemia (CML) and around 20% in acute lymphoblastic leukemia (ALL). The finding of this fusion gene is essential for diagnosis of CML by detection of various fusi...
متن کاملThe ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
Although the BCR-ABL hybrid gene on chromosome 22q-plays a pivotal role in the pathogenesis of chronic myeloid leukemia (CML), little is known of the reciprocal chimeric gene, ABL-BCR, formed on chromosome 9q+. By reverse transcription/polymerase chain reaction amplification (RT/PCR) we have detected ABL-BCR mRNA in cells from 31 of 44 BCR-ABL positive CML patients and 3 of 5 CML cell lines. Of...
متن کاملAn In-House Method for Molecular Monitoring of BCR-ABL
OBJECTIVE At present, there are a limited number of facilities in Turkey that can provide reliable real-time quantitative(RQ)-PCR BCR-ABL results. The present study aimed to test a cost-effective, in-house method of BCR-ABL quantification,including verification of the method by RQ-PCR validation tests. MATERIAL AND METHODS BCR-ABL and ABL target sequences were cloned into pJET1.2 vectors, fro...
متن کامل